Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
Review Article

Curcumin: A Dietary Phytochemical for Targeting the Phenotype and Function of Dendritic Cells

Author(s): Kaveh Rahimi, Kambiz Hassanzadeh, Hashem Khanbabaei, Saeed M. Haftcheshmeh, Abbas Ahmadi, Esmael Izadpanah, Asadollah Mohammadi* and Amirhossein Sahebkar*

Volume 28, Issue 8, 2021

Published on: 15 May, 2020

Page: [1549 - 1564] Pages: 16

DOI: 10.2174/0929867327666200515101228

Price: $65

conference banner
Abstract

Dendritic cells (DCs) are the most powerful antigen-presenting cells which link the innate and adaptive immune responses. Depending on the context, DCs initiate the immune responses or contribute to immune tolerance. Any disturbance in their phenotypes and functions may initiate inflammatory or autoimmune diseases. Hence, dysregulated DCs are the most attractive pharmacological target for the development of new therapies aiming at reducing their immunogenicity and at enhancing their tolerogenicity. Curcumin is the polyphenolic phytochemical component of the spice turmeric with a wide range of pharmacological activities. It acts in several ways as a modulator of DCs and converts them into tolerogenic DCs. Tolerogenic DCs possess anti-inflammatory and immunomodulatory activities that regulate the immune responses in health and disease. Curcumin by blocking maturation markers, cytokines and chemokines expression, and disrupting the antigen-presenting machinery of DCs render them non- or hypo-responsive to immunostimulants. It also reduces the expression of co-stimulatory and adhesion molecules on DCs and prevents them from both migration and antigen presentation but enhances their endocytosis capacity. Hence, curcumin causes DCs-inducing regulatory T cells and dampens CD4+ T helper 1 (Th1), Th2, and Th17 polarization. Inhibition of transcription factors such as NF-κB, AP-1, MAPKs (p38, JNK, ERK) and other intracellular signaling molecules such as JAK/STAT/SOCS provide a plausible explanation for most of these observations. In this review, we summarize the potential effects of curcumin on the phenotypes and functions of DCs as the key players in orchestration, stimulation, and modulation of the immune responses.

Keywords: Curcumin, immunomodulator, dendritic cells, autoimmunity, inflammation, diatery phytochemical, dendritic cells.

« Previous Next »
[1]
Santos, PM; Butterfield, LH Dendritic cell-based cancer vaccines. J. Immunol., 2018, 200(2), 443-449.
[http://dx.doi.org/10.4049/jimmunol.1701024] [PMID: 29311386]
[2]
Sabado, R.L.; Balan, S.; Bhardwaj, N. Dendritic cell-based immunotherapy. Cell Res., 2017, 27(1), 74-95.
[http://dx.doi.org/10.1038/cr.2016.157] [PMID: 28025976]
[3]
Constantino, J.; Gomes, C.; Falcão, A.; Neves, B.M.; Cruz, M.T. Dendritic cell-based immunotherapy: a basic review and recent advances. Immunol. Res., 2017, 65(4), 798-810.
[http://dx.doi.org/10.1007/s12026-017-8931-1] [PMID: 28660480]
[4]
Bol, K.F.; Schreibelt, G.; Gerritsen, W.R.; de Vries, I.J.; Figdor, C.G. Dendritic cell-based immunotherapy: state of the art and beyond. Clin. Cancer Res., 2016, 22(8), 1897-1906.
[http://dx.doi.org/10.1158/1078-0432.ccr-15-1399] [PMID: 27084743]
[5]
Shang, N.; Figini, M.; Shangguan, J.; Wang, B.; Sun, C.; Pan, L.; Ma, Q.; Zhang, Z. Dendritic cells based immunotherapy. Am. J. Cancer Res., 2017, 7(10), 2091-2102.
[PMID: 29119057]
[6]
Panahi, Y.; Hosseini, M.S.; Khalili, N.; Naimi, E.; Simental-Mendía, L.E.; Majeed, M.; Sahebkar, A. Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial.Biomed. Pharmacother; , 2016, 82, pp. 578-582.
[http://dx.doi.org/10.1016/j.biopha.2016.05.037] [PMID: 27470399]
[7]
Gupta, S.C.; Patchva, S.; Koh, W.; Aggarwal, B.B. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin. Exp. Pharmacol. Physiol., 2012, 39(3), 283-299.
[http://dx.doi.org/10.1111/j.1440-1681.2011.05648.x] [PMID: 22118895]
[8]
Aggarwal, B.B.; Sung, B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci., 2009, 30(2), 85-94.
[http://dx.doi.org/10.1016/j.tips.2008.11.002] [PMID: 19110321]
[9]
Mohammadi, A.; Fazeli, B.; Taheri, M.; Sahebkar, A.; Poursina, Z.; Vakili, V. Modulatory effects of curcumin on apoptosis and cytotoxicity-related molecules in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients. Biomed. Pharmacother., 2017, 85, 457-462.
[http://dx.doi.org/10.1016/j.biopha.2016.11.050] [PMID: 27894665]
[10]
Poursina, Z.; Mohammadi, A.; Yazdi, S.Z.; Humpson, I.; Vakili, V.; Boostani, R.; Rafatpanah, H. Curcumin increased the expression of c-FLIP in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients. J. Cell. Biochem., 2019, 120(9), 15740-15745.
[http://dx.doi.org/10.1002/jcb.28843] [PMID: 31074052]
[11]
Panahi, Y.; Kianpour, P.; Mohtashami, R.; Jafari, R.; Simental-Mendía, L.E.; Sahebkar, A. Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial. Drug Res. (Stuttg.), 2017, 67(4), 244-251.
[http://dx.doi.org/10.1055/s-0043-100019] [PMID: 28158893]
[12]
Abdollahi, E.; Momtazi, A.A.; Johnston, T.P.; Sahebkar, A. Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: a nature-made jack-of-all-trades? J. Cell. Physiol., 2018, 233(2), 830-848.
[http://dx.doi.org/10.1002/jcp.25778] [PMID: 28059453]
[13]
Iranshahi, M.; Sahebkar, A.; Hosseini, S.T.; Takasaki, M.; Konoshima, T.; Tokuda, H. Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine, 2010, 17(3-4), 269-273.
[http://dx.doi.org/10.1016/j.phymed.2009.05.020] [PMID: 19577457]
[14]
Momtazi, A.A.; Sahebkar, A. Difluorinated curcumin: A promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile.Curr. Pharmaceut. Design., 22(28), 4386-4397.
[http://dx.doi.org/10.2174/1381612822666160527113501] [PMID: 27229723]
[15]
Mollazadeh, H.; Cicero, A.F.G.; Blesso, C.N.; Pirro, M.; Majeed, M.; Sahebkar, A. Immune modulation by curcumin: the role of interleukin-10. Crit. Rev. Food Sci. Nutr., 2019, 59(1), 89-101.
[http://dx.doi.org/10.1080/10408398.2017.1358139] [PMID: 28799796]
[16]
Rezaee, R.; Momtazi, A.A.; Monemi, A.; Sahebkar, A. Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity. Pharmacol. Res., 2017, 117, 218-227.
[http://dx.doi.org/10.1016/j.phrs.2016.12.037] [PMID: 28042086]
[17]
Sahebkar, A. Molecular mechanisms for curcumin benefits against ischemic injury. Fertil. Steril., 2010, 94(5), e75-e76.
[http://dx.doi.org/10.1016/j.fertnstert.2010.07.1071] [PMID: 20797714]
[18]
Srivastava, R.M.; Singh, S.; Dubey, S.K.; Misra, K.; Khar, A. Immunomodulatory and therapeutic activity of curcumin. Int. Immunopharmacol., 2011, 11(3), 331-341.
[http://dx.doi.org/10.1016/j.intimp.2010.08.014] [PMID: 20828642]
[19]
Lin, J.K. Molecular targets of curcumin. Adv. Exp. Med. Biol., 2007, 595, 227-243.
[http://dx.doi.org/10.1007/978-0-387-46401-5_10] [PMID: 17569214]
[20]
Zhou, H.; Beevers, C.S.; Huang, S. The targets of curcumin. Curr. Drug Targets, 2011, 12(3), 332-347.
[http://dx.doi.org/10.2174/138945011794815356] [PMID: 20955148]
[21]
Mohammadi, A.; Blesso, C.N.; Barreto, G.E.; Banach, M.; Majeed, M.; Sahebkar, A. Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent. J. Nutr. Biochem., 2019, 66, 1-16.
[http://dx.doi.org/10.1016/j.jnutbio.2018.12.005] [PMID: 30660832]
[22]
Rahimi, K.; Ahmadi, A.; Hassanzadeh, K.; Soleimani, Z.; Sathyapalan, T.; Mohammadi, A.; Sahebkar, A. Targeting the balance of T helper cell responses by curcumin in inflammatory and autoimmune states. Autoimmun. Rev., 2019, 18(7), 738-748.
[http://dx.doi.org/10.1016/j.autrev.2019.05.012] [PMID: 31059845]
[23]
The Nobel lectures in immunology. The Nobel prize for physiology or medicine, 1908, awarded to Elie Metchnikoff & Paul Ehrlich “in recognition of their work on immunity”. Scand. J. Immunol., 1990, 31(1), 1-13.
[PMID: 2405475]
[24]
Hashimoto, D.; Miller, J.; Merad, M. Dendritic cell and macrophage heterogeneity in vivo. Immunity, 2011, 35(3), 323-335.
[http://dx.doi.org/10.1016/j.immuni.2011.09.007] [PMID: 21943488]
[25]
Mohammadi, A.; Sharifi, A.; Pourpaknia, R.; Mohammadian, S.; Sahebkar, A. Manipulating macrophage polarization and function using classical HDAC inhibitors: Implications for autoimmunity and inflammation. Crit. Rev. Oncol. Hematol., 2018, 128, 1-18.
[http://dx.doi.org/10.1016/j.critrevonc.2018.05.009] [PMID: 29958625]
[26]
Shapouri-Moghaddam, A.; Mohammadian, S.; Vazini, H.; Taghadosi, M.; Esmaeili, S.A.; Mardani, F.; Seifi, B.; Mohammadi, A.; Afshari, J.T.; Sahebkar, A. Macrophage plasticity, polarization, and function in health and disease. J. Cell. Physiol., 2018, 233(9), 6425-6440.
[http://dx.doi.org/10.1002/jcp.26429] [PMID: 29319160]
[27]
Momtazi-Borojeni, A.A.; Haftcheshmeh, S.M.; Esmaeili, S-A.; Johnston, T.P.; Abdollahi, E.; Sahebkar, A. Curcumin: a natural modulator of immune cells in systemic lupus erythematosus. Autoimmun. Rev., 2018, 17(2), 125-135.
[http://dx.doi.org/10.1016/j.autrev.2017.11.016] [PMID: 29180127]
[28]
Merad, M.; Sathe, P.; Helft, J.; Miller, J.; Mortha, A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol., 2013, 31, 563-604.
[http://dx.doi.org/10.1146/annurev-immunol-020711-074950] [PMID: 23516985]
[29]
O’Keeffe, M.; Mok, W.H.; Radford, K.J. Human dendritic cell subsets and function in health and disease. Cell. Mol. Life Sci., 2015, 72(22), 4309-4325.
[http://dx.doi.org/10.1007/s00018-015-2005-0] [PMID: 26243730]
[30]
Geissmann, F.; Manz, M.G.; Jung, S.; Sieweke, M.H.; Merad, M.; Ley, K. Development of monocytes, macrophages, and dendritic cells. Science, 2010, 327(5966), 656-661.
[http://dx.doi.org/10.1126/science.1178331] [PMID: 20133564]
[31]
Liu, J.; Cao, X. Regulatory dendritic cells in autoimmunity: A comprehensive review. J. Autoimmun., 2015, 63, 1-12.
[http://dx.doi.org/10.1016/j.jaut.2015.07.011] [PMID: 26255250]
[32]
Takenaka, M.C.; Quintana, F.J. Tolerogenic dendritic cells. Semin. Immunopathol., 2017, 39(2), 113-120.
[http://dx.doi.org/10.1007/s00281-016-0587-8] [PMID: 27646959]
[33]
Rea, D.; van Kooten, C.; van Meijgaarden, K.E.; Ottenhoff, T.H.; Melief, C.J.; Offringa, R. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood, 2000, 95(10), 3162-3167.
[http://dx.doi.org/10.1182/blood.V95.10.3162] [PMID: 10807783]
[34]
Moser, M.; De Smedt, T.; Sornasse, T.; Tielemans, F.; Chentoufi, A.A.; Muraille, E.; Van Mechelen, M.; Urbain, J.; Leo, O. Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur. J. Immunol., 1995, 25(10), 2818-2824.
[http://dx.doi.org/10.1002/eji.1830251016] [PMID: 7589077]
[35]
Matasić, R.; Dietz, A.B.; Vuk-Pavlović, S. Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. J. Leukoc. Biol., 1999, 66(6), 909-914.
[http://dx.doi.org/10.1002/jlb.66.6.909] [PMID: 10614771]
[36]
Berer, A.; Stöckl, J.; Majdic, O.; Wagner, T.; Kollars, M.; Lechner, K.; Geissler, K.; Oehler, L. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp. Hematol., 2000, 28(5), 575-583.
[http://dx.doi.org/10.1016/S0301-472X(00)00143-0] [PMID: 10812248]
[37]
Xie, Z.; Chen, J.; Zheng, C.; Wu, J.; Cheng, Y.; Zhu, S.; Lin, C.; Cao, Q.; Zhu, J.; Jin, T. 1,25-dihydroxyvitamin D3 -induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells. Immunology, 2017, 152(3), 414-424.
[http://dx.doi.org/10.1111/imm.12776] [PMID: 28617989]
[38]
Adorini, L.; Penna, G. Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb. Exp. Pharmacol., 2009, (188), 251-273.
[http://dx.doi.org/10.1007/978-3-540-71029-5_12] [PMID: 19031030]
[39]
Ferreira, G.B.; Kleijwegt, F.S.; Waelkens, E.; Lage, K.; Nikolic, T.; Hansen, D.A.; Workman, C.T.; Roep, B.O.; Overbergh, L.; Mathieu, C. Differential protein pathways in 1,25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells. J. Proteome Res., 2012, 11(2), 941-971.
[http://dx.doi.org/10.1021/pr200724e] [PMID: 22103328]
[40]
Penna, G; Adorini, L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. (Baltimore, Md : 1950)., 2000, 164(5), 2405-2411.
[41]
Canning, M.O.; Grotenhuis, K.; de Wit, H.; Ruwhof, C.; Drexhage, H.A. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur. J. Endocrinol., 2001, 145(3), 351-357.
[http://dx.doi.org/10.1530/eje.0.1450351] [PMID: 11517017]
[42]
Ferreira, G.B.; Overbergh, L.; Verstuyf, A.; Mathieu, C. 1α,25-Dihydroxyvitamin D3 and its analogs as modulators of human dendritic cells: a comparison dose-titration study. J. Steroid Biochem. Mol. Biol., 2013, 136, 160-165.
[http://dx.doi.org/10.1016/j.jsbmb.2012.10.009] [PMID: 23098690]
[43]
Gregori, S.; Casorati, M.; Amuchastegui, S.; Smiroldo, S.; Davalli, A.M.; Adorini, L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol., 2001, 167(4), 1945-1953.
[http://dx.doi.org/10.4049/jimmunol.167.4.1945] [PMID: 11489974]
[44]
Mehling, A.; Grabbe, S.; Voskort, M.; Schwarz, T.; Luger, T.A.; Beissert, S. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J. Immunol., 2000, 165(5), 2374-2381.
[http://dx.doi.org/10.4049/jimmunol.165.5.2374] [PMID: 10946260]
[45]
Colic, M.; Stojic-Vukanic, Z.; Pavlovic, B.; Jandric, D.; Stefanoska, I. Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells. Clin. Exp. Immunol., 2003, 134(1), 63-69.
[http://dx.doi.org/10.1046/j.1365-2249.2003.02269.x] [PMID: 12974756]
[46]
Turnquist, H.R.; Raimondi, G.; Zahorchak, A.F.; Fischer, R.T.; Wang, Z.; Thomson, A.W. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J. Immunol., 2007, 178(11), 7018-7031.
[http://dx.doi.org/10.4049/jimmunol.178.11.7018] [PMID: 17513751]
[47]
Horibe, E.K.; Sacks, J.; Unadkat, J.; Raimondi, G.; Wang, Z.; Ikeguchi, R.; Marsteller, D.; Ferreira, L.M.; Thomson, A.W.; Lee, W.P.; Feili-Hariri, M. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Transpl. Immunol., 2008, 18(4), 307-318.
[http://dx.doi.org/10.1016/j.trim.2007.10.007] [PMID: 18158116]
[48]
Hackstein, H.; Taner, T.; Zahorchak, A.F.; Morelli, A.E.; Logar, A.J.; Gessner, A.; Thomson, A.W. Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood, 2003, 101(11), 4457-4463.
[http://dx.doi.org/10.1182/blood-2002-11-3370] [PMID: 12531798]
[49]
Hackstein, H.; Morelli, A.E.; Larregina, A.T.; Ganster, R.W.; Papworth, G.D.; Logar, A.J. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J. Immunol., 2001, 166(12), 7053-7062.
[http://dx.doi.org/10.4049/jimmunol.166.12.7053] [PMID: 11390449]
[50]
Buckland, M.; Jago, C.; Fazekesova, H.; George, A.; Lechler, R.; Lombardi, G. Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells. Int. Immunopharmacol., 2006, 6(13-14), 1895-1901.
[http://dx.doi.org/10.1016/j.intimp.2006.07.008] [PMID: 17219690]
[51]
Matasic, R.; Dietz, A.B.; Vuk-Pavlovic, S. Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin. Immunology, 2000, 101(1), 53-60.
[http://dx.doi.org/10.1046/j.1365-2567.2000.00065.x] [PMID: 11012753]
[52]
Cai, D.T.; Ho, Y.H.; Chiow, K.H.; Wee, S.H.; Han, Y.; Peh, M.T.; Wong, S.H. Aspirin regulates SNARE protein expression and phagocytosis in dendritic cells. Mol. Membr. Biol., 2011, 28(2), 90-102.
[http://dx.doi.org/10.3109/09687688.2010.525756] [PMID: 21231793]
[53]
Verhasselt, V.; Vanden Berghe, W.; Vanderheyde, N.; Willems, F.; Haegeman, G.; Goldman, M. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J. Immunol., 1999, 162(5), 2569-2574.
[PMID: 10072497]
[54]
Millard, A.L.; Mertes, P.M.; Ittelet, D.; Villard, F.; Jeannesson, P.; Bernard, J. Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin. Exp. Immunol., 2002, 130(2), 245-255.
[http://dx.doi.org/10.1046/j.0009-9104.2002.01977.x] [PMID: 12390312]
[55]
Liu, L.; Li, L.; Min, J.; Wang, J.; Wu, H.; Zeng, Y.; Chen, S.; Chu, Z. Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells. Cell. Immunol., 2012, 277(1-2), 66-73.
[http://dx.doi.org/10.1016/j.cellimm.2012.05.011] [PMID: 22698927]
[56]
Wang, B.; Morinobu, A.; Horiuchi, M.; Liu, J.; Kumagai, S. Butyrate inhibits functional differentiation of human monocyte-derived dendritic cells. Cell. Immunol., 2008, 253(1-2), 54-58.
[http://dx.doi.org/10.1016/j.cellimm.2008.04.016] [PMID: 18522857]
[57]
Li, J.; Li, J.; Zhang, F. The immunoregulatory effects of Chinese herbal medicine on the maturation and function of dendritic cells. J. Ethnopharmacol., 2015, 171, 184-195.
[http://dx.doi.org/10.1016/j.jep.2015.05.050] [PMID: 26068430]
[58]
Aldahlawi, A.M. Modulation of dendritic cell immune functions by plant components. J. Micros. Ultrastruct., 2016, 4(2), 55-62.
[http://dx.doi.org/10.1016/j.jmau.2016.01.001] [PMID: 30023210]
[59]
Ebadi, P.; Karimi, M.H.; Amirghofran, Z. Plant components for immune modulation targeting dendritic cells: implication for therapy. Immunotherapy, 2014, 6(10), 1037-1053.
[http://dx.doi.org/10.2217/imt.14.77] [PMID: 25428644]
[60]
Rogers, N.M.; Kireta, S.; Coates, P.T. Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo. Clin. Exp. Immunol., 2010, 162(3), 460-473.
[http://dx.doi.org/10.1111/j.1365-2249.2010.04232.x] [PMID: 21070208]
[61]
Kim, G-Y.; Kim, K-H.; Lee, S-H.; Yoon, M-S.; Lee, H-J.; Moon, D-O. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J. Immunol., 2005, 174(12), 8116-8124.
[http://dx.doi.org/10.4049/jimmunol.174.12.8116] [PMID: 15944320]
[62]
Shirley, S.A.; Montpetit, A.J.; Lockey, R.F.; Mohapatra, S.S. Curcumin prevents human dendritic cell response to immune stimulants. Biochem. Biophys. Res. Commun., 2008, 374(3), 431-436.
[http://dx.doi.org/10.1016/j.bbrc.2008.07.051] [PMID: 18639521]
[63]
Krasovsky, J.; Chang, D.H.; Deng, G.; Yeung, S.; Lee, M.; Leung, P.C.; Cunningham-Rundles, S.; Cassileth, B.; Dhodapkar, M.V. Inhibition of human dendritic cell activation by hydroethanolic but not lipophilic extracts of turmeric (Curcuma longa). Planta Med., 2009, 75(4), 312-315.
[http://dx.doi.org/10.1055/s-0028-1088367] [PMID: 19034830]
[64]
Kumar, A.; Dhawan, S.; Hardegen, N.J.; Aggarwal, B.B. Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. Biochem. Pharmacol., 1998, 55(6), 775-783.
[http://dx.doi.org/10.1016/S0006-2952(97)00557-1] [PMID: 9586949]
[65]
Sandur, S.K.; Pandey, M.K.; Sung, B.; Ahn, K.S.; Murakami, A.; Sethi, G.; Limtrakul, P.; Badmaev, V.; Aggarwal, B.B. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis, 2007, 28(8), 1765-1773.
[http://dx.doi.org/10.1093/carcin/bgm123] [PMID: 17522064]
[66]
Sebolt-Leopold, J.S. Development of anticancer drugs targeting the MAP kinase pathway. Oncogene, 2000, 19(56), 6594-6599.
[http://dx.doi.org/10.1038/sj.onc.1204083] [PMID: 11426644]
[67]
Seger, R.; Krebs, E.G. The MAPK signaling cascade. FASEB J., 1995, 9(9), 726-735.
[http://dx.doi.org/10.1096/fasebj.9.9.7601337] [PMID: 7601337]
[68]
Singh, S.; Aggarwal, B.B. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J. Biol. Chem., 1995, 270(42), 24995-25000.
[http://dx.doi.org/10.1074/jbc.270.42.24995] [PMID: 7559628]
[69]
Arrighi, J.F.; Rebsamen, M.; Rousset, F.; Kindler, V.; Hauser, C. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J. Immunol., 2001, 166(6), 3837-3845.
[http://dx.doi.org/10.4049/jimmunol.166.6.3837] [PMID: 11238627]
[70]
An, H.; Yu, Y.; Zhang, M.; Xu, H.; Qi, R.; Yan, X.; Liu, S.; Wang, W.; Guo, Z.; Guo, J.; Qin, Z.; Cao, X. Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology, 2002, 106(1), 38-45.
[http://dx.doi.org/10.1046/j.1365-2567.2002.01401.x] [PMID: 11972630]
[71]
Bharti, A.C.; Donato, N.; Singh, S.; Aggarwal, B.B. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood, 2003, 101(3), 1053-1062.
[http://dx.doi.org/10.1182/blood-2002-05-1320] [PMID: 12393461]
[72]
O’Shea, J.J.; Plenge, R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity, 2012, 36(4), 542-550.
[http://dx.doi.org/10.1016/j.immuni.2012.03.014] [PMID: 22520847]
[73]
Huang, R-Y.; Yu, Y-L.; Cheng, W-C.; OuYang, C-N.; Fu, E.; Chu, C-L. Immunosuppressive effect of quercetin on dendritic cell activation and function. J. Immunol., 2010, 184(12), 6815-6821.
[http://dx.doi.org/10.4049/jimmunol.0903991] [PMID: 20483746]
[74]
Kahkhaie, K.R.; Mirhosseini, A.; Aliabadi, A.; Mohammadi, A.; Mosavi, M.J.; Haftcheshmeh, S.M. Curcumin: a modulator of inflammatory signaling pathways in the immune system. Inflammopharmacology, 2019, 27(5), 885-900.
[http://dx.doi.org/10.1007/s10787-019-00607-3 ] [PMID: 31140036]
[75]
Zhao, H-M.; Xu, R.; Huang, X-Y.; Cheng, S-M.; Huang, M-F.; Yue, H-Y.; Wang, X.; Zou, Y.; Lu, A.P.; Liu, D.Y. curcumin suppressed activation of dendritic cells via JAK/STAT/SOCS signal in mice with experimental colitis. Front. Pharmacol., 2016, 7(455), 455.
[http://dx.doi.org/10.3389/fphar.2016.00455] [PMID: 27932984]
[76]
Renkl, A.C.; Wussler, J.; Ahrens, T.; Thoma, K.; Kon, S.; Uede, T.; Martin, S.F.; Simon, J.C.; Weiss, J.M. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood, 2005, 106(3), 946-955.
[http://dx.doi.org/10.1182/blood-2004-08-3228] [PMID: 15855273]
[77]
Cantor, H.; Shinohara, M.L. Regulation of T-helper-cell lineage development by osteopontin: the inside story. Nat. Rev. Immunol., 2009, 9(2), 137-141.
[http://dx.doi.org/10.1038/nri2460] [PMID: 19096390]
[78]
O’Regan, A.W.; Chupp, G.L.; Lowry, J.A.; Goetschkes, M.; Mulligan, N.; Berman, J.S. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J. Immunol., 1999, 162(2), 1024-1031.
[PMID: 9916729]
[79]
Koguchi, Y.; Kawakami, K.; Uezu, K.; Fukushima, K.; Kon, S.; Maeda, M.; Nakamoto, A.; Owan, I.; Kuba, M.; Kudeken, N.; Azuma, M.; Yara, S.; Shinzato, T.; Higa, F.; Tateyama, M.; Kadota, J.; Mukae, H.; Kohno, S.; Uede, T.; Saito, A. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am. J. Respir. Crit. Care Med., 2003, 167(10), 1355-1359.
[http://dx.doi.org/10.1164/rccm.200209-1113OC] [PMID: 12574077]
[80]
Xu, G.; Nie, H.; Li, N.; Zheng, W.; Zhang, D.; Feng, G.; Ni, L.; Xu, R.; Hong, J.; Zhang, J.Z. Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J. Clin. Invest., 2005, 115(4), 1060-1067.
[http://dx.doi.org/10.1172/JCI200523273] [PMID: 15761492]
[81]
Kourepini, E.; Aggelakopoulou, M.; Alissafi, T.; Paschalidis, N.; Simoes, D.C.; Panoutsakopoulou, V. Osteopontin expression by CD103- dendritic cells drives intestinal inflammation. Proc. Natl. Acad. Sci. USA, 2014, 111(9), E856-E865.
[http://dx.doi.org/10.1073/pnas.1316447111] [PMID: 24550510]
[82]
Sato, T.; Nakai, T.; Tamura, N.; Okamoto, S.; Matsuoka, K.; Sakuraba, A.; Fukushima, T.; Uede, T.; Hibi, T. Osteopontin/Eta-1 upregulated in Crohn’s disease regulates the Th1 immune response. Gut, 2005, 54(9), 1254-1262.
[http://dx.doi.org/10.1136/gut.2004.048298] [PMID: 16099792]
[83]
Comabella, M.; Pericot, I.; Goertsches, R.; Nos, C.; Castillo, M.; Blas Navarro, J.; Río, J.; Montalban, X. Plasma osteopontin levels in multiple sclerosis. J. Neuroimmunol., 2005, 158(1-2), 231-239.
[http://dx.doi.org/10.1016/j.jneuroim.2004.09.004] [PMID: 15589058]
[84]
Murugaiyan, G.; Mittal, A.; Weiner, H.L. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J. Immunol., 2008, 181(11), 7480-7488.
[http://dx.doi.org/10.4049/jimmunol.181.11.7480] [PMID: 19017937]
[85]
Lv, J.; Shao, Q.; Wang, H.; Shi, H.; Wang, T.; Gao, W.; Song, B.; Zheng, G.; Kong, B.; Qu, X. Effects and mechanisms of curcumin and basil polysaccharide on the invasion of SKOV3 cells and dendritic cells. Mol. Med. Rep., 2013, 8(5), 1580-1586.
[http://dx.doi.org/10.3892/mmr.2013.1695] [PMID: 24065177]
[86]
Chen, Y.J.; Wei, Y.Y.; Chen, H.T.; Fong, Y.C.; Hsu, C.J.; Tsai, C.H.; Hsu, H.C.; Liu, S.H.; Tang, C.H. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells. J. Cell. Physiol., 2009, 221(1), 98-108.
[http://dx.doi.org/10.1002/jcp.21835] [PMID: 19475568]
[87]
Yang, G.; Zhang, Y.; Wu, J.; Xiong, J.; Deng, H.; Wang, J.; Yang, C.; Zhu, Z. Osteopontin regulates growth and migration of human nasopharyngeal cancer cells. Mol. Med. Rep., 2011, 4(6), 1169-1173.
[http://dx.doi.org/10.3892/mmr.2011.538] [PMID: 21785824]
[88]
Philip, S.; Kundu, G.C. Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J. Biol. Chem., 2003, 278(16), 14487-14497.
[http://dx.doi.org/10.1074/jbc.M207309200] [PMID: 12473670]
[89]
Walsh, K.P.; Mills, K.H. Dendritic cells and other innate determinants of T helper cell polarisation. Trends Immunol., 2013, 34(11), 521-530.
[http://dx.doi.org/10.1016/j.it.2013.07.006] [PMID: 23973621]
[90]
Raphael, I.; Nalawade, S.; Eagar, T.N.; Forsthuber, T.G. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine, 2015, 74(1), 5-17.
[http://dx.doi.org/10.1016/j.cyto.2014.09.011] [PMID: 25458968]
[91]
Peron, G.; de Lima Thomaz, L.; Camargo da Rosa, L.; Thomé, R.; Cardoso Verinaud, L.M. Modulation of dendritic cell by pathogen antigens: Where do we stand? Immunol. Lett., 2018, 196, 91-102.
[http://dx.doi.org/10.1016/j.imlet.2018.02.001] [PMID: 29427742]
[92]
Cong, Y.; Wang, L.; Konrad, A.; Schoeb, T.; Elson, C.O. Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells. Eur. J. Immunol., 2009, 39(11), 3134-3146.
[http://dx.doi.org/10.1002/eji.200939052] [PMID: 19839007]
[93]
Yoneyama, S.; Kawai, K.; Tsuno, N.H.; Okaji, Y.; Asakage, M.; Tsuchiya, T.; Yamada, J.; Sunami, E.; Osada, T.; Kitayama, J.; Takahashi, K.; Nagawa, H. Epigallocatechin gallate affects human dendritic cell differentiation and maturation. J. Allergy Clin. Immunol., 2008, 121(1), 209-214.
[http://dx.doi.org/10.1016/j.jaci.2007.08.026] [PMID: 17935769]
[94]
Svajger, U.; Obermajer, N.; Jeras, M. Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation. Immunology, 2010, 129(4), 525-535.
[http://dx.doi.org/10.1111/j.1365-2567.2009.03205.x] [PMID: 20002210]
[95]
Yang, X.; Lv, J-N.; Li, H.; Jiao, B.; Zhang, Q.H.; Zhang, Y. Curcumin reduces lung inflammation via Wnt/beta-catenin signaling in mouse model of asthma. J. Asthma, 2017, 54(4), 335-340.
[http://dx.doi.org/10.1080/02770903.2016.1218018] [PMID: 27715343]
[96]
Jung, I.D.; Lee, C.M.; Jeong, Y.I.; Lee, J.S.; Park, W.S.; Han, J.; Park, Y.M. Differential regulation of indoleamine 2,3-dioxygenase by lipopolysaccharide and interferon gamma in murine bone marrow derived dendritic cells. FEBS Lett., 2007, 581(7), 1449-1456.
[http://dx.doi.org/10.1016/j.febslet.2007.02.073] [PMID: 17367785]
[97]
Mellor, A.L.; Lemos, H.; Huang, L. Indoleamine 2,3-dioxygenase and tolerance: where are we now? Front. Immunol., 2017, 8, 1360.
[http://dx.doi.org/10.3389/fimmu.2017.01360] [PMID: 29163470]
[98]
Mellor, A.L.; Munn, D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol., 2004, 4(10), 762-774.
[http://dx.doi.org/10.1038/nri1457] [PMID: 15459668]
[99]
Lemos, H.; Huang, L.; Prendergast, G.C.; Mellor, A.L. Immune control by amino acid catabolism during tumorigenesis and therapy. Nat. Rev. Cancer, 2019, 19(3), 162-175.
[http://dx.doi.org/10.1038/s41568-019-0106-z] [PMID: 30696923]
[100]
Jung, I.D.; Jeong, Y.I.; Lee, C.M.; Noh, K.T.; Jeong, S.K.; Chun, S.H.; Choi, O.H.; Park, W.S.; Han, J.; Shin, Y.K.; Kim, H.W.; Yun, C.H.; Park, Y.M. COX-2 and PGE2 signaling is essential for the regulation of IDO expression by curcumin in murine bone marrow-derived dendritic cells. Int. Immunopharmacol., 2010, 10(7), 760-768.
[http://dx.doi.org/10.1016/j.intimp.2010.04.006] [PMID: 20399909]
[101]
Jeong, Y.I.; Kim, S.W.; Jung, I.D.; Lee, J.S.; Chang, J.H.; Lee, C.M.; Chun, S.H.; Yoon, M.S.; Kim, G.T.; Ryu, S.W.; Kim, J.S.; Shin, Y.K.; Lee, W.S.; Shin, H.K.; Lee, J.D.; Park, Y.M. Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells. J. Biol. Chem., 2009, 284(6), 3700-3708.
[http://dx.doi.org/10.1074/jbc.M807328200] [PMID: 19075017]
[102]
Vilekar, P.; Awasthi, S.; Natarajan, A.; Anant, S.; Awasthi, V. EF24 suppresses maturation and inflammatory response in dendritic cells. Int. Immunol., 2012, 24(7), 455-464.
[http://dx.doi.org/10.1093/intimm/dxr121] [PMID: 22378503]
[103]
Cho, J.W.; Lee, K.S.; Kim, C.W. Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int. J. Mol. Med., 2007, 19(3), 469-474.
[PMID: 17273796]
[104]
Seifarth, C.C.; Hinkmann, C.; Hahn, E.G.; Lohmann, T.; Harsch, I.A. Reduced frequency of peripheral dendritic cells in type 2 diabetes. Exp. Clin. Endocrinol. Diabetes, 2008, 116(3), 162-166.
[http://dx.doi.org/10.1055/s-2007-990278] [PMID: 18213547]
[105]
Mráz, M.; Cinkajzlová, A.; Kloučková, J.; Lacinová, Z.; Kratochvílová, H.; Lipš, M.; Pořízka, M.; Kopecký, P.; Lindner, J.; Kotulák, T.; Netuka, I.; Haluzík, M. Dendritic cells in subcutaneous and epicardial adipose tissue of subjects with type 2 diabetes, obesity, and coronary artery disease. Mediators Inflamm., 2019.20195481725
[http://dx.doi.org/10.1155/2019/5481725] [PMID: 31210749]
[106]
Yekollu, S.K.; Thomas, R.; O’Sullivan, B. Targeting curcusomes to inflammatory dendritic cells inhibits NF-κB and improves insulin resistance in obese mice. Diabetes, 2011, 60(11), 2928-2938.
[http://dx.doi.org/10.2337/db11-0275] [PMID: 21885868]
[107]
Steinbach, E.C.; Plevy, S.E. The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm. Bowel Dis., 2014, 20(1), 166-175.
[http://dx.doi.org/10.1097/MIB.0b013e3182a69dca] [PMID: 23974993]
[108]
Bates, J.; Diehl, L. Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity? J. Pathol., 2014, 232(2), 112-120.
[http://dx.doi.org/10.1002/path.4277] [PMID: 24122796]
[109]
Beloqui, A.; Memvanga, P.B.; Coco, R.; Reimondez-Troitiño, S.; Alhouayek, M.; Muccioli, G.G.; Alonso, M.J.; Csaba, N.; de la Fuente, M.; Préat, V. A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease. Colloids Surf. B Biointerfaces, 2016, 143, 327-335.
[http://dx.doi.org/10.1016/j.colsurfb.2016.03.038] [PMID: 27022873]
[110]
Hanai, H.; Sugimoto, K. Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr. Pharm. Des., 2009, 15(18), 2087-2094.
[http://dx.doi.org/10.2174/138161209788489177] [PMID: 19519446]
[111]
Sreedhar, R.; Arumugam, S.; Thandavarayan, R.A.; Karuppagounder, V.; Watanabe, K. Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease. Drug Discov. Today, 2016, 21(5), 843-849.
[http://dx.doi.org/10.1016/j.drudis.2016.03.007] [PMID: 26995272]
[112]
Baliga, M.S.; Joseph, N.; Venkataranganna, M.V.; Saxena, A.; Ponemone, V.; Fayad, R. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations. Food Funct., 2012, 3(11), 1109-1117.
[http://dx.doi.org/10.1039/c2fo30097d] [PMID: 22833299]
[113]
Vecchi Brumatti, L.; Marcuzzi, A.; Tricarico, P.M.; Zanin, V.; Girardelli, M.; Bianco, A.M. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. Molecules, 2014, 19(12), 21127-21153.
[http://dx.doi.org/10.3390/molecules191221127] [PMID: 25521115]
[114]
Larmonier, C.B.; Uno, J.K.; Lee, K.M.; Karrasch, T.; Laubitz, D.; Thurston, R.; Midura-Kiela, M.T.; Ghishan, F.K.; Sartor, R.B.; Jobin, C.; Kiela, P.R. Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection. Am. J. Physiol. Gastrointest. Liver Physiol., 2008, 295(5), G1079-G1091.
[http://dx.doi.org/10.1152/ajpgi.90365.2008] [PMID: 18818316]
[115]
Zhao, H-M.; Xu, R.; Huang, X-Y.; Cheng, S-M.; Huang, M-F.; Yue, H-Y.; Wang, X.; Zou, Y.; Lu, A.P.; Liu, D.Y. Curcumin improves regulatory T cells in gut-associated lymphoid tissue of colitis mice. World J. Gastroenterol., 2016, 22(23), 5374-5383.
[http://dx.doi.org/10.3748/wjg.v22.i23.5374] [PMID: 27340353]

Rights & Permissions Print Cite
Article Metrics
53
2
Wayfinder Image
World Antimicrobial Awareness Week
© 2024 Bentham Science Publishers | Privacy Policy